Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (2757)	5/22/1998 3:30:00 PM
From: Anthony Wong	Respond to of 9523

Stock Decline Seen As Buying Opportunity Dow Jones News Story Analysts, however, continue to recommend purchase of Pfizer's stock. Kenneth Nover, an analyst with A.G. Edwards & Sons Inc., said there is no indication that the six deaths were caused by Viagra in any way. He sees Friday's price decline as all the more reason to buy Pfizer's stock. He noted, however, that because the stock has risen to such lofty levels spurred by the positive news from Viagra, any negative news is likely to have a drastic effect. Indeed, Pfizer's stock has risen more than 45% since the beginning of the year. -By Jennifer Fron Mauer; 201-938-5287; jennifer-fron.mauer@cor.dowjones.com

To: Mkilloran who wrote (2757)	5/22/1998 3:31:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Options Report Elsewhere in the options market: - As concerns about Viagra drive Pfizer Inc. stock lower, the June 100 puts are getting a lot of attention. The contract is the most actively traded contract at the four options exchanges. The put is up 1 at 2 1/16 on volume of 6,098 contracts, compared with open interest of 7,308 contracts. (END) DOW JONES NEWS 05-22-98 03:18 PM